Overview

Decorin in Sub Scleral Trabeculectomy

Status:
Not yet recruiting

Trial end date:
2022-01-01

Target enrollment:

Participant gender:

Summary

This is a prospective, single-center, interventional, randomized controlled study comparing Decorin as antifibrotic agent in sub scleral trabeculectomy versus Mitomycin.

Phase:

Phase 1

Details

Lead Sponsor:

Cairo University

Collaborator:

University of Luebeck

Treatments:

Mitomycin
Mitomycins